Catalog No.
MVV04602
Species reactivity
Human herpesvirus 1 (HSV-1/HHV-1)
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Immunogen
E. coli - derived recombinant HSV-1 gG / US4 (Gly24-Asp189).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:5000
Target
Envelope glycoprotein G,gG,gG-1,gG,US4
Concentration
0.78 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P06484
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1A074
Herpes simplex virus type 1 modifies the protein composition of extracellular vesicles to promote neurite outgrowth and neuroinfection., PMID:38275838
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G., PMID:36114130
The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's Disease., PMID:31297637
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands., PMID:26755775
Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential., PMID:25532518
Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies., PMID:25377426
Identification of an immunodominant epitope in glycoproteins B and G of herpes simplex viruses (HSVs) using synthetic peptides as antigens in assay of antibodies to HSV in herpes simplex encephalitis patients., PMID:25283862
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections., PMID:24496316
Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples., PMID:22696877
Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling., PMID:22318154
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006., PMID:22085620
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing., PMID:21658271
Application and expression of HSV gG1 protein from a recombinant strain., PMID:20705103
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies., PMID:20171247
Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2., PMID:20007366
[Genital herpes]., PMID:19177764
Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera., PMID:17989200
Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a type-specific enzyme-linked immunosorbent assay kit., PMID:17521395
[Expression of multi-copy and immuno-reactivity of recombinant type-specific epitope of herpes simplex virus type 1]., PMID:16894929
Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies., PMID:16758036
Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study., PMID:16709538
Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1., PMID:15966705
Type-specific reactivity of anti-glycoprotein G antibodies from herpes simplex virus-infected individuals is maintained by single or dual type-specific residues., PMID:15659743
Seroprevalence of HSV-1 and HSV-2 in Barbados., PMID:15156399
Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study., PMID:15113449
Seroepidemiology of herpes simplex type 2 in pregnant women in Belgium., PMID:15107632
Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay., PMID:14715543
Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2., PMID:14671972
Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study., PMID:14514152
Herpes simplex virus infection of the human eye induces a compartmentalized virus-specific B cell response., PMID:12447728
Characterization of B virus glycoprotein antibodies induced by DNA immunization., PMID:12417944
Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates., PMID:12202560
Performance and use of HSV type-specific serology test kits., PMID:12106510
Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies., PMID:12089274
Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics., PMID:11880443
Frequency of herpes simplex virus in Syria based on type-specific serological assay., PMID:11533818
Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic., PMID:11416087
Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands., PMID:11158114
Corneal macrophage infiltrates following ocular herpes simplex virus type 1 challenge vary in BALB/c mice vaccinated with different vaccines., PMID:11137266
Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies., PMID:10725430
Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1., PMID:10548571
Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies., PMID:10534733
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy., PMID:10448394
The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies., PMID:10382821
Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro., PMID:10364346
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples., PMID:10325351
Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan., PMID:10229273
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2., PMID:9889222
Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors., PMID:9837796
For research use only. Not for human or drug use.
